PAPatrícia Alvarez

Patrícia Alvarez

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Patrícia Alvarez has a total of 185 co-authors. Here are the top co-authors by number of shared publications:

  • Marisa Ribeiro

    Laboratório de Tecnologia Diagnóstica (LATED), Instituto de Tecnologia de Imunobiológicos (Bio‐Manguinhos) Fundação Oswaldo Cruz (Fiocruz) Rio de Janeiro Brasil

    11 shared publications
  • Rodrigo Brindeiro

    Fundação Oswaldo Cruz-Fiocruz, Brazil; Universidade Federal do Rio de Janeiro, Brazil

    11 shared publications
  • Daniele Rocha

    Laboratório de Tecnologia Diagnóstica (LATED), Instituto de Tecnologia de Imunobiológicos (Bio‐Manguinhos) Fundação Oswaldo Cruz (Fiocruz) Rio de Janeiro Brasil

    10 shared publications
  • Elaine Costa

    Laboratório de Tecnologia Diagnóstica (LATED), Instituto de Tecnologia de Imunobiológicos (Bio‐Manguinhos) Fundação Oswaldo Cruz (Fiocruz) Rio de Janeiro Brasil

    10 shared publications
  • Elisabete Andrade

    Laboratório de Tecnologia Diagnóstica (LATED), Instituto de Tecnologia de Imunobiológicos (Bio‐Manguinhos) Fundação Oswaldo Cruz (Fiocruz) Rio de Janeiro Brasil

    9 shared publications
  • Marcela Fontana-Maurell

    Fundação Oswaldo Cruz-Fiocruz, Brazil; Universidade Federal do Rio de Janeiro, Brazil

    7 shared publications

Latest Publications

  • Open Access

    Molecular screening of arboviruses in asymptomatic blood donors from Northern Brazil

    by Alexandre Rodrigues Calazans, Vanessa Duarte da Costa, Marisa de Oliveira Ribeiro, Barbara Araújo Nogueira, Élida Millena de Vasconcelos Brandão, Katia Cristina Silva Nascimento, Luiz Paulo de Brito Oliveira Souza, Priscilla Lopes da Silva Guimarães, Pedro Henrique Cardoso, Alexandre Vicente Frederico, et al.

    Background: Asymptomatic infections caused by the arboviruses dengue virus (DENV), zika virus (ZIKV) and chikungunya virus (CHIKV) pose a hidden risk to blood safety, as viremic donors may contribute to transfusion-transmitted infections with severe outcomes. Methods: Viral RNA from 5,954 pools (each pool contains six samples) was extracted using the Chemagic™ Prime™ platform, as part of the Brazilian NAT PLUS system from pooled plasma samples collected at Amazonas Hematology and Hemotherapy Hospital Foundation (HEMOAM) and analyzed by RT-qPCR using the ZC D- Tipagem molecular assay (Bio-Manguinhos). Results: Over eighteen consecutive epidemiological weeks, 11 CHIKV-positive cases were identified, 4 DENV-positive cases, and no ZIKV-positive detections on the blood bags samples analyzed. Conclusion: The detection of asymptomatic arboviral infections during the rainy season, when environmental conditions favor mosquito proliferation and arbovirus transmission, suggests ongoing silent viral circulation in the region and reinforces the importance of blood donor surveillance.

  • Open Access

    The risk of transfusion-transmitted infection: First evidence of Oropouche virus detection in an asymptomatic blood donor in Southeastern Brazil

    by Patrícia Alvarez, Marisa de Oliveira Ribeiro, Josiane Iole, Daniele Barbosa de Almeida Medeiros, Gabriel da Luz Wallau, Lívia Medeiros Neves Casseb, Deusilene Souza Vieira Dall'ACqua, Luiz Amorim, Mônica Barcellos Arruda


  • Open Access

    Evaluation of HDV stability under different biological sample collection and storage conditions: implications for molecular diagnosis

    by Jackson Alves da Silva Queiroz, Mônica Barcellos Arruda, Tárcio Peixoto Roca, Adrhyan Araújo, Ana Maísa Passos-Silva, Eugênia de Castro e Silva, Lourdes Maria Pinheiro Borzacov, Alexandre Rodrigues Calazans, Juan Miguel Villalobos Salcedo, Patrícia Alvarez da Silva Baptista, et al.

    In Brazil, the Amazon region has the highest rate of infection by the hepatitis Delta virus, and owing to regional difficulties in transporting and storing samples, especially in remote regions and isolated populations, the expansion of molecular diagnosis has become a significant public health problem. This study aims to analyze the stability of HDV under different temperature and storage conditions, providing essential information for the expansion of the molecular diagnosis of Hepatitis Delta. Whole blood, serum, and plasma samples were collected from chronic HDV patients. The samples were subjected to different temperatures and storage conditions, and HDV-RNA detection was performed via RT-qPCR. HDV was stable under various temperature conditions, including high temperatures, with minimal variations in Ct values. Compared with cryopreserved samples, DBS samples presented greater variation. The results suggest that HDV can remain detectable for up to 96 h when stored at room temperature, 4 °C, -30 °C, and − 80 °C and for up to 72 h at temperatures ranging from 4 °C to 42 °C, in addition to the possibility of detection via filter paper, although with reduced sensitivity. HDV is stable under different conditions, which is crucial for molecular diagnostics in regions with adverse storage conditions.


  • Open Access

    Detecting Arboviruses Through Screening Asymptomatic Blood Donors in Rio de Janeiro/Brazil During a Dengue Outbreak

    by Marisa de Oliveira Ribeiro, Mônica Barcellos Arruda, Alexandre Rodrigues Calazans, Alexandre Vicente Frederico, Anielly Ferreira Brito, Beatriz Vasconcello de Souza Barreto, Élida Millena de Vasconcelos Brandão, Hamilton Athayde, Kátia Cristina Silva Nascimento, Luiz Paulo de Brito Oliveira Souza, et al.

    Arthropod-borne viruses (arboviruses) dengue (DENV), chikungunya (CHIK), and Zika (ZIKV) have been responsible for a high number of outbreaks worldwide. However, their screening in blood donors is not mandatory, and asymptomatic cases might act as an important cause of virus transmission via transfusion. A study was conducted to assess the presence of DENV (serotypes 1–4), ZIKV, and CHIKV in pooled samples (pool size: six) from asymptomatic blood donors. A total of 9463 plasma pools, corresponding to 56,778 blood donations from asymptomatic blood donors who attended donor sessions at HEMORIO and other blood centers in Rio de Janeiro and Espírito Santo, was submitted to automated nucleic-acid extraction and PCR amplification using ZC D-Tipagem molecular assay (Bio-Manguinhos). In general, a pool prevalence of 1% (95/9463) and a donor prevalence of 0.17% (95/56,778) were observed. January and February 2024 had a total of 62 positive pools out of 95 (65.3%). Targets DENV-1 and -2 had a higher prevalence in the studied months—early summer—with 24 and 28 positive pools, respectively. ZC D-Tipagem molecular assay was able to detect the best-known arboviruses circulating in asymptomatic blood donors; this study suggested that ZIKV, CHIK, and DENV are circulating in asymptomatic blood donors before blood donations and can be transmitted to blood transfusion recipients.


  • Open Access

    Retrospective Analysis of Omicron in Minas Gerais, Brazil: Emergence, Dissemination, and Diversification

    by Paula Luize Camargos Fonseca, Isabela Braga-Paz, Luiza Campos Guerra de Araújo e Santos, Rillery Calixto Dias, Carolina Senra Alves de Souza, Nara Oliveira Carvalho, Daniel Costa Queiroz, Hugo José Alves, João Locke Ferreira de Araújo, Filipe Romero Rebello Moreira, et al.

    Brazil is one of the countries most affected by COVID-19, with the highest number of deaths recorded. Brazilian Health Institutions have reported four main peaks of positive COVID-19 cases. The last two waves were characterized by the emergence of the VOC Omicron and its sublineages. This study aimed to conduct a retrospective surveillance study illustrating the emergence, dissemination, and diversification of the VOC Omicron in 15 regional health units (RHUs) in MG, the second most populous state in Brazil, by combining epidemiological and genomic data. A total of 5643 confirmed positive COVID-19 samples were genotyped using the panels TaqMan SARS-CoV-2 Mutation and 4Plex SC2/VOC Bio-Manguinhos to define mutations classifying the BA.1, BA.2, BA.4, and BA.5 sublineages. While sublineages BA.1 and BA.2 were more prevalent during the third wave, BA.4 and BA.5 dominated the fourth wave in the state. Epidemiological and viral genome data suggest that age and vaccination with booster doses were the main factors related to clinical outcomes, reducing the number of deaths, irrespective of the Omicron sublineages. Complete genome sequencing of 253 positive samples confirmed the circulation of the BA.1, BA.2, BA.4, and BA.5 subvariants, and phylogenomic analysis demonstrated that the VOC Omicron was introduced through multiple international events, followed by transmission within the state of MG. In addition to the four subvariants, other lineages have been identified at low frequency, including BQ.1.1 and XAG. This integrative study reinforces that the evolution of Omicron sublineages was the most significant factor driving the highest peaks of positive COVID-19 cases without an increase in more severe cases, prevented by vaccination boosters.

  • Differential diagnosis of exanthematous viruses during the 2022 Mpox outbreak in Minas Gerais, Brazil

    by Talita Émile Ribeiro Adelino, Sara Cândida Santos, Maurício Teixeira Lima, Alana Vitor Barbosa da Costa, Natália Rocha Guimarães, Luiz Marcelo Ribeiro Tomé, Marcos Vinícius Ferreira Silva, Amanda Matos Pereira, Kelly Cristina Magalhães Luiz, Ludmila Oliveira Lamounier, et al.

    The monkeypox virus (MPXV) outbreak, primarily endemic to Africa, has spread globally, with Brazil reporting the second-highest number of cases. The emergence of MPXV in non-endemic areas has raised concerns, particularly due to the co-circulation of other exanthematous viruses such as varicella-zoster virus (VZV) and molluscum contagiosum virus (MOCV). To perform an accurate differential diagnosis of MPXV during the ongoing outbreak in Minas Gerais, Brazil, a 5PLEX qPCR assay targeting orthopoxviruses (OPV), VZV, and MOCV was used to retrospectively analyze all clinical samples that tested negative for MPXV in the initial screening conducted at Funed. In summary, our study analyzed 1,175 clinical samples received from patients suspected of MPXV infection and found a positivity rate of 33.8% (397 samples) for MPXV using the non-variola qPCR assay. Testing the 778 MPXV-negative clinical samples using the 5PLEX qPCR assay revealed that 174 clinical samples (22.36%) tested positive for VZV. MOCV DNA was detected in 13 and other OPV in 3 clinical samples. The sequencing of randomly selected amplified clinical samples confirmed the initial molecular diagnosis. Analysis of patient profiles revealed a significant difference in the median age between groups testing positive for MPXV and VZV and a male predominance in MPXV cases. The geographic distribution of positive cases was concentrated in the most populous mesoregions of Minas Gerais state. This study highlights the challenges posed by emerging infectious diseases. It emphasizes the importance of epidemiological surveillance and accurate diagnosis in enabling timely responses for public health policies and appropriate medical care. IMPORTANCE: Brazil ranks second in the number of cases during the global monkeypox epidemic. The study, conducted in Minas Gerais, the second most populous state in Brazil with over 20 million inhabitants, utilized differential diagnostics, revealing a significant number of positive cases for other exanthematous viruses and emphasizing the need for accurate diagnoses. During the study, we were able to assess the co-circulation of other viruses alongside monkeypox, including varicella-zoster virus, molluscum contagiosum virus, and other orthopoxviruses. The significance of the research is underscored by the concentration of positive cases in populous areas, highlighting the challenges posed by emerging infectious diseases. This demographic context further amplifies the importance of the research in guiding public health policies and medical interventions, given the substantial population at risk. The study not only addresses a global concern but also holds critical implications for a state with such a large population and geographic expanse within Brazil. Overall, the study emphasizes the pivotal role of surveillance and precise diagnosis in guiding effective public health responses and ensuring appropriate medical interventions.


  • Detection of Plasmodium spp. in asymptomatic blood donors by the new Brazilian NAT PLUS HIV/HBV/HCV/Malaria Bio‐Manguinhos kit

    by Elaine Costa, Daniele Rocha, Josiane Iole França Lopes, Elisabete Andrade, Pedro Cardoso, Marisa Ribeiro, Marcela Fontana‐Maurell, Amanda Roberta Revoredo Vicentino, Alexandre Rodrigues Calazans, Monica Barcellos Arruda, et al.

    Background: Transfusion‐transmitted malaria (TTM) is a public health problem in endemic and nonendemic areas. The Brazilian Ministry of Health (MH) requested the development of a nucleic acid amplification test (NAT) for the detection of Plasmodium spp. in public blood centers to increase blood safety.Study Design and Methods: The new Brazilian NAT kit named NAT PLUS HIV/HBV/HCV/Malaria Bio‐Manguinhos was first implemented in HEMORIO, a public blood center in the city of Rio de Janeiro. Since October 1, 2022, this blood center has been testing all its blood donations for malaria in a pool of six plasma samples to detect Plasmodium spp. by real‐time polymerase chain reaction (PCR).Results: Since the implementation of the NAT PLUS platform until February 2023, HEMORIO has successfully received and tested 200,277 donations. The platform detected two asymptomatic donors in the city of Rio de Janeiro, which is a nonendemic region for malaria. Our analyses suggested a malaria from the Amazon region caused by Plasmodium vivax, in the first case, while an autochthonous transmission case by Plasmodium malariae was identified in the rural area of Rio de Janeiro state.Discussion: The NAT PLUS platform detects Plasmodium spp. in plasma samples with sensitivity capable of detecting subpatent infections. This is the first time worldwide that a group developed and implemented molecular diagnosis for Plasmodium spp. to be used by public blood centers to avoid TTM.


  • Open Access

    Influenza A, like Omicron SARS-CoV-2, Is Similarly Detected in Saliva or Nasopharyngeal Samples via RT-qPCR

    by Hellen Abreu, Carla Adriane Royer, Carolina Gracia Poitevin, Ana Flávia Kohler, Ana Carolina Rodrigues, Sonia Mara Raboni, Meri Bordignon Nogueira, Pedro Henrique Cardoso, Monica Barcellos Arruda, Patrícia Alvarez da Silva Baptista, et al.

    After the Coronavirus pandemic, the importance of virus surveillance was highlighted, reinforcing the constant necessity of discussing and updating the methods for collection and diagnoses, including for other respiratory viruses. Although the nasopharyngeal swab is the gold-standard sample for detecting and genotyping SARS-CoV-2 and Influenza viruses, its collection is uncomfortable and requires specialized teams, which can be costly. During the pandemic, non-invasive saliva samples proved to be a suitable alternative for SARS-CoV-2 diagnosis, but for Influenza virus the use of this sample source is not recognized yet. In addition, most SARS-CoV-2 comparisons were conducted before the Omicron variant emerged. Here, we aimed to compare Influenza A and Omicron RT-qPCR analysis of nasopharyngeal swabs and saliva self-collection in paired samples from 663 individuals. We found that both nasopharyngeal swab and saliva collection are efficient for the diagnosis of Omicron (including sub-lineages) and for Influenza A, with high sensitivity and accuracy (>90%). The kappa index is 0.938 for Influenza A and 0.905 for SARS-CoV-2. These results showed excellent agreement between the two samples reinforcing saliva samples as a reliable source for detecting Omicron and highlighting saliva as a valid sample source for Influenza detection, considering this cheaper and more comfortable alternative.


  • Open Access

    A straightforward one-step strategy for SARS-CoV-2 diagnosis and screening of variants of concern: a multicentre study

    by Marcela Fontana-Maurell, Fernando Do Couto Motta, Monica Barcellos Arruda, Pedro Cardoso, Marisa Ribeiro, Elisabete Andrade, Daniela T Godoy, Elaine Costa, Daniele Rocha, Marilda Agudo Mt Siqueira, et al.

    The prevalence of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) variants of concern (VOCs) has changed unevenly over time around the world. Although whole genome sequencing is the gold standard for virus characterisation, the discovery of alpha VOC causing spike gene target failure (SGTF) result, when tested using an reverse transcription real-time polymerase chain reaction (RT-qPCR) assay, has provided a simple tool for tracking the frequencies of variants. The aim of this study was to investigate if a multiplex RT-qPCR assay (BioM 4Plex VOC) could be used to detect SARS-CoV-2 and to perform a VOC screening test in a single reaction tube. Here, we present the multicentre study evaluating this assay. Twelve laboratories have participated in the multicentre study. The BioM 4Plex VOC was distributed to them with detailed instructions of how to perform the test. They were asked to test the BioM 4Plex VOC in parallel with their routine Commercial SARS-CoV-2 diagnostic assay. Additionally, they were requested to select SARS-CoV-2-positive samples with genome sequenced and lineage definition according to PANGO lineage classification. The BioM 4Plex VOC and commercial RT-PCR assay are equally effective in detecting SARS-CoV-2. Results revealed a specificity of 96.5-100% [95% confidence interval (CI)], a sensitivity of 99.8-100% (95% CI), and an accuracy of 99.8-100% (95% CI). A 99% concordance rate was found between results from the BioM 4Plex VOC and that from available genome sequencing data. The BioM 4Plex VOC provides an effective solution to detect SARS-CoV-2 infections and screening for VOCs in a single reaction. It is a straightforward method to help us monitor the frequency and distribution of VOCs and develop strategies to better cope with the pandemics.


  • Open Access

    Evaluation of the Panbio COVID-19 Antigen Rapid Diagnostic Test in Subjects Infected with Omicron Using Different Specimens

    by Rafael Mello Galliez, Larissa Bomfim, Diana Mariani, Isabela de Carvalho Leitão, Anna Carla Pinto Castiñeiras, Cassia Cristina Alves Gonçalves, Bianca Ortiz da Silva, Pedro Henrique Cardoso, Monica Barcelos Arruda, Patricia Alvarez, et al.

    This study showed that the antigen rapid test for COVID19 worked fine using nasal swabs when it was utilized in patients infected with the Omicron variant, showing a concordance with PCR in 93% of patients tested. The nasal swab yielded more reliable results than the oral swab when an antigen rapid diagnosis test (the Panbio COVID-19 antigen rapid diagnostic test) was used in patients infected with the Omicron variant.